Access to anti-retroviral drugs, male in Bangladesh
Bangladesh: Access to anti-retroviral drugs, male was 45.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Bangladesh, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in Bangladesh stood at 45.0%. That is the highest value across all 25 years on record.
That represents a change of up 9.8% on the previous year and up 309.1% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Bangladesh peaked at 45.0% in 2024 and was at its lowest, 0.0%, in 2000.
Bangladesh ranks 125th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Bangladesh, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 1.0% | — |
| 2007 | 1.0% | +0.0% |
| 2008 | 3.0% | +200.0% |
| 2009 | 4.0% | +33.3% |
| 2010 | 5.0% | +25.0% |
| 2011 | 7.0% | +40.0% |
| 2012 | 8.0% | +14.3% |
| 2013 | 10.0% | +25.0% |
| 2014 | 11.0% | +10.0% |
| 2015 | 11.0% | +0.0% |
| 2016 | 13.0% | +18.2% |
| 2017 | 19.0% | +46.2% |
| 2018 | 22.0% | +15.8% |
| 2019 | 24.0% | +9.1% |
| 2020 | 30.0% | +25.0% |
| 2021 | 31.0% | +3.3% |
| 2022 | 35.0% | +12.9% |
| 2023 | 41.0% | +17.1% |
| 2024 | 45.0% | +9.8% |
Bangladesh compared with similar countries
- Bangladesh's 45.0% is below the median for lower middle income countries, which is 71.0%, 63% of the median. (39 countries reporting)
- Bangladesh's 45.0% is below the median for South Asia, which is 62.0%, 73% of the median. (5 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, male in Bangladesh changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2008 | +200.0% | 1.0% | 3.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.9% | 0.0% | 4.0% | 10 |
| 2010s | 13.0% | 5.0% | 24.0% | 10 |
| 2020s | 36.4% | 30.0% | 45.0% | 5 |
Countries ranked near Bangladesh
More gender data for Bangladesh
- Child population (UN estimates and projections) 48,868 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.1434 % change on previous year (2030)
- Population 137,205 (2030)
- Working-age population (UN estimates and projections) 137,205 (2030)
- Population (UN estimates and projections), annual growth rate 1.43 % change on previous year (2030)
- Age population, age 00, female, interpolated 1.66 million (2025)
- Age population, age 00, male, interpolated 1.74 million (2025)
- Age population, age 01, female, interpolated 1.66 million (2025)
- Age population, age 01, male, interpolated 1.74 million (2025)
- Age population, age 02, female, interpolated 1.66 million (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Bangladesh?
- Access to anti-retroviral drugs, male in Bangladesh was 45.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Bangladesh?
- The highest recorded value was 45.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Bangladesh?
- The lowest recorded value was 0.0% in 2000.
- How does Bangladesh rank for access to anti-retroviral drugs, male?
- Bangladesh ranks 125th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Bangladesh?
- Over the last ten years it is up 309.1%. The long-run trend across the full record is volatile.
- Where does this Bangladesh data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.